Gene Query: CNPY3

Dataset Description Geneva Score
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 34.43
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 29.79
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 26.01
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 21.82
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 21.82
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 21.39
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 21.39
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 21.14
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 20.25
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 19.04
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 19.0
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 18.34
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 18.21
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 18.0
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 17.28
Stem and effector CD8 T-cells from human cancers 17.22
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 15.97
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 15.66
Human neutrophil genome during PMA- and E. coli encounter-induced activation 15.66
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 15.34
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 14.76
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 14.61
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 14.53
Transcriptomes of human monocytes after ex vivo exposure to uric acid 13.88
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 13.86
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 13.86
Human cells contain natural double-stranded RNAs with potential regulatory capacity 13.63
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 13.56
ZIKV infection of monocytes activates inflammasome pathways 13.55
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 13.53
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 13.4
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 13.33
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 13.06
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 13.06
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 12.78
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 12.74
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 12.72
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 12.67
RNA-sequencing of formalin fixed human primary melanoma tissue 12.56
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 12.36
METTL3 promotes translation in human cancer cells 12.35
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 12.33
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 12.33
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 12.31
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 12.14
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 12.03
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.86
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 11.8
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 11.8
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 11.72
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 11.53
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 11.46
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 11.36
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 11.31
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 11.28
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 11.28
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 11.26
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 11.16
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 11.11
Transcriptional profiles of normal human mature B cells 11.05
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 11.04
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 11.0
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 10.99
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 10.88
The comparison of high-throughput single-cell RNA-seq methods 10.72
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 10.61
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 10.56
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 10.23
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 10.13
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 10.06
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 10.01
RNA expression analysis upon JMJD1C depletion 9.84
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 9.84
Mutational landscape of splicing genes and functional consequences across 33 cancer types 9.82
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 9.8
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 9.76
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 9.76
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 9.6
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 9.45
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 9.38
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 9.37
Transcriptional profiling of microglia; current state of the art and future perspectives 9.36
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 9.33
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 9.33
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 9.3
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 9.25
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 9.0
Genome wide expression change by RNF168 knocking down in NEC cells 9.0
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 8.87
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 8.8
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 8.73
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 8.68
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.56
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.56
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 8.55
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 8.54
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 8.44
Effect of Hotair overexpression in human breast cancer cell lines 8.42
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 8.41
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 8.4
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 8.39
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 8.28
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 8.25
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 8.22
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 8.22
The evolution of N6-methyladenosine in primates 8.19
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.14
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 8.13
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 8.13
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 8.13
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 8.08
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.07
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 7.98
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 7.96
Differetially expressed genes after hTR overexpression in U2OS cells 7.93
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 7.92
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 7.84
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 7.74
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 7.73
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 7.61
Transcriptome of diurnal human blood neutrophils 7.57
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 7.57
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 7.57
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 7.54
Paxillin regulates genomic networks in prostate cancer [C4-2] 7.51
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 7.49
TGF-β regulation of miRNA expression in pancreatic cancer 7.48
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 7.48
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 7.48
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 7.48
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 7.46
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 7.43
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 7.35
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 7.33
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 7.31
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 7.31
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 7.29
Impact of dieldrin on transcription in Jurkat T cells 7.28
Energy Metabolism during Anchorage-Independence 7.2
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 7.13
CircRNAome diversity in human mature B-cells, T-cells and monocytes 7.08
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 7.04
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 7.04
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 7.03
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 7.03
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 7.01
Intron retention induced by microsatellite expansions as a disease biomarker. 6.85
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.77
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.75
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.71
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 6.69
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 6.68
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.67
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 6.65
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 6.65
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 6.62
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 6.61
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 6.59
TAF1 is critical for AE driven leukemogenesis 6.59
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 6.56
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 6.53
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 6.5
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 6.48
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 6.42
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 6.41
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.38
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 6.37
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 6.34
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.32
Triple vectors expand AAV transfer capacity in the retina 6.3
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.3
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 6.23
Identification of renal resident macrophages across species 6.18
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.17
The role of FAM46C in myeloma cells 6.15
The role of FAM46C in myeloma cells [sequencing] 6.15
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 6.14
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 6.14
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 6.06
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 6.06
miRNAs affected by antagomiR-17 treatment 6.02
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.02
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.0
CROP-Seq in Primary Human T Cells 5.95
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 5.94
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 5.94
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.93
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 5.93
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 5.91
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 5.89
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.88
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 5.88
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.83
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 5.83
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.8
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 5.78
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 5.78
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 5.76
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 5.74
scRNASeq analysis of cycling cardiomyocytes 5.73
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 5.73
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 5.73
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 5.69
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 5.68
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 5.65
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 5.65
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 5.64
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 5.64
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 5.6
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 5.6
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 5.58
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 5.58
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 5.57
Trascriptome of thyroid cancer-induced macrophages 5.55
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.47
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 5.46
Gene expression changes due to PARP knockdown in human cells 5.43
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 5.43
Effect of from Human Umbilical Vein Endothelial Cells 5.43
Macrophage Ad5f35 M2 Challenge 5.42
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 5.42
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 5.41
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 5.36
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 5.35
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.35
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 5.34
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 5.3
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 5.29
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 5.28
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 5.28
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 5.27
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 5.27
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 5.24
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 5.15
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 5.12
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 5.12
miR941 overexpression experiment 5.11
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.1
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 5.07
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 5.05
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 5.05
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.05
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.05
Ectoderm specification of H1 human embryonic stem cells 5.04
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 5.04
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 5.04
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 5.03
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 4.96
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 4.96
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 4.91
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 4.91
BACH2 in human plasma cell fate decision 4.89
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 4.88
Total RNA-seq in ALL-SIL upon JQ1 inhibition 4.84
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 4.84
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.8
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 4.79
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 4.77
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.74
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 4.72
Identification of renal resident macrophages across species [C1] 4.72
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 4.69
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.69
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.69
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 4.68
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 4.63
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.62
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 4.59
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 4.58
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 4.58
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.58
Transcriptome analysis of CNS leukemia 4.58
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 4.55
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 4.52
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 4.52
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 4.47
Single-cell analysis of adult human ovary using 10X genomics 4.41
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.33
Transcriptome analysis of peripheral blood monocytes 4.28
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.27
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.21
MARCKS and lnc-MARCKS act as inflammation regulators 4.21
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 4.2
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 4.18
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 4.18
Silencing SPIB in attached and floating state of H1703 lung cancer cells 4.13
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 4.09
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 4.07
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 4.07
Transcription control by the ENL YEATS domain in acute leukemia 4.06
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 4.06
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 4.04
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 4.0
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 3.89
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 3.89
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 3.88
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 3.86
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.86
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 3.84
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 3.75
Iron response of HepG2 cells 3.74
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.73
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.64
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.63
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 3.62
Gene expressions of H9s in different culture systems 3.56
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 3.55
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.53
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.51
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 3.51
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.48
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.46
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 3.39
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.37
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.37
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.37
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 3.34
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.33
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.33
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.33
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 3.28
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 3.28
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.19
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 3.08
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 3.08
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 3.08
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.03
Transcriptome of Stabilin-1 siRNA transfected human monocytes 3.01
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.99
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.92
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 2.89
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 2.89
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.87
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.84
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.82
Identification of a LIF-responsive replication-competent human β cell 2.76
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.73
Tpl-2 small molecule project 2.73
Tpl-2 and MEK small molecule inhibitors 2.73
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 2.73
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.72
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.72
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.68
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.65
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 2.62
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 2.61
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 2.59
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.53
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 2.49
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.47
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.46
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.44
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.42
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.42
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.42
RNA-Seq and expression data from human adipose tissue 2.42
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.38
Functional significance of the HIV-1 Tat signature amino acid residues 2.37
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.37
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 2.37
Reprogrammed myeloid cell transcriptomes in NSCLC 2.36
Transcriptome sequencing of K-562 cells 2.35
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.35
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.35
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 2.29
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.27
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.26
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.25
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.22
Transcription elongation regulates genome 3D structure 2.22
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 2.18
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 2.16
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 2.16
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 2.15
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.13
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 2.12
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 2.12
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 2.12
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.1
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 2.1
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 2.03
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.0
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.94
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.93
NAPRT activation of macrophages 1.92
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.9
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 1.9
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 1.9
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.9
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.89
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.88
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.86
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.85
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.84
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 1.8
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.8
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.73
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.72
RNA sequencing of T-ALL (COG study) 1.65
Analyses of T-ALL (COG study) 1.65
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.62
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.61
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.6
MicroRNA-125a-5p overexpression in human macrophages 1.6
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.52
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.52
Copper Regulation of HIF-1 Transcription Activity 1.5
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.5
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.48
Human Treg NaCl stimulation 1.46
Illumina Total RNA-seq in HeLa 1.44
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.39
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.37
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.37
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.37
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.37
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.36
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.36
RNA-Sequencing of HepG2 cells treated with TGFBeta 1.35
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.34
Measure transcript integrity using RNA-seq data 1.24
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.23
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.22
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.17
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 1.17
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.11
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 1.1
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.08
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 1.08
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.08
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.05
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.05
Transcriptomes in healthy and CHB fetal hearts 1.05
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 1.05
Gene expression profile in breast cancer cells 1.03
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.03
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.02
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.01
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.97
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.97
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.96
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.95
Total RNA-Seq data from leukemic patients with complex structural variants 0.93
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.92
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.92
The pioneer factor CEBPA modulates vitamin D signaling 0.91
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.91
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.9
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.9
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.85
Ribosomal protein RPL26 is the principal target of UFMylation 0.85
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.83
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.81
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.81
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.79
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.78
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.77
Enhancer activation during EGF response 0.72
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.69
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.68
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.68
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.66
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.65
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.64
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.6
Metabolism as an early predictor of DPSCs aging 0.6
Ribosome profiling upon inhibition of eIF4A 0.57
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.55
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.48
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.46
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.46
RNA-seq of primary patient AML samples 0.43
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.42
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.42
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.42
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.39
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.38
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.38
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.37
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.37
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.37
RNA-Seq of PRMT1 overexpression ECA109 cells 0.37
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.35
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 0.32
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.32
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.3
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 0.29
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.27
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.26
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.25
MHC Transcriptomic landscape at haplotype-specific resolution 0.21
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.18
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.18
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.15
The role of m6A/m-RNA methylation in stress response regulation 0.09
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.09
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.06
Gene expression activation in CLL mediated by MSCs contact 0.06
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.06
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation